weight;word
528;in vivo
427;vitro
414;vivo
414;in vitro
108;mass spectrometry
98;approach
90;flow cytometry
70;electron microscopy
56;situ
52;X-ray crystallography
50;meta-analysis
40;NMR spectroscopy
36;Phylogenetic analysis
36;whole-exome sequencing
34;Western blotting
34;RT-PCR
32;methods
30;ex vivo
30;cryo-EM
28;cryo-electron microscopy
28;experiment
26;transmission electron microscopy
24;RNA sequencing
24;site-directed mutagenesis
24;fluorescence microscopy
22;Western blot analysis
22;qRT-PCR
20;silico
20;new method
20;Mass spectrometry
20;procedure
20;next-generation sequencing
18;vitro and in vivo
18;ex vivo
18;experiments
16;central composite design
16;in 
16;In 
16;small-angle X-ray scattering
16;SDS-PAGE
16;analyses
16;super-resolution microscopy
16;confocal microscopy
16;Molecular dynamics simulations
16;Western blot
14;Proteomic analysis
14;live-cell imaging
14;algorithms
14;quantitative proteomics
14;PCR-RFLP
14;trial
14;single-cell RNA sequencing
14;Raman spectroscopy
14;high-throughput sequencing
14;phylogenetic analysis
14;microarray analysis
14;situ hybridization
14;Electron microscopy
14;principal component analysis
14;isothermal titration calorimetry
14;genome-wide association study
14;statistical analysis
12;immunohistochemical analysis
12;ChIP-seq
12;multivariate analysis
12;machine learning
12;quantitative mass spectrometry
12;RNA-seq
12;in situ
12;analytical ultracentrifugation
12;scanning electron microscopy
12;program
12;LC-MS/MS
12;silico analysis
12;exome sequencing
12;cross-sectional study
10;in-depth analysis
10;online survey
10;workflow
10;meta-analyses
10;real-time PCR
10;assay
10;genome-wide association studies
10;Cluster analysis
10;size-exclusion chromatography
10;CE-Symm
10;statistical approach
10;electron tomography
10;circular dichroism
10;Flow cytometry
10;Genome-wide analysis
10;Transcriptome analysis
10;western blot
10;surface plasmon resonance
10;Cancer Genome Atlas
10;mass spectrometry (MS)
10;Sequence analysis
10;genome-wide association studies (GWASs)
10;s.l.
8;Health Research
8;integrated approach
8;MR-seq
8;genome-wide association study (GWAS)
8;single-breath carbon dioxide test
8;western blotting
8;machine learning approach
8;prospective study
8;follow-up
8;deep sequencing
8;high-resolution mass spectrometry
8;vivo studies
8;Computational methods
8;single experiment
8;GC/MS
8;cryo-electron tomography
8;proteomic analysis
8;structural analysis
8;Network analysis
8;size exclusion chromatography
8;2D-PAGE
8;MLVA scheme
8;light microscopy
8;Statistical analysis
8;RNA-Seq
8;pathway analysis
8;survey
8;live imaging
8;genome-wide association studies (GWAS)
8;systems biology approach
8;logistic regression
8;Site-directed mutagenesis
8;Bioinformatic analysis
8;randomized controlled trial
8;Meta-analysis
8;I–
8;DNA sequencing
8;intravital microscopy
8;Principal component analysis
8;single-particle analysis
8;nuclear magnetic resonance spectroscopy
8;computational methods
8;Φ-value analysis
8;electron cryomicroscopy
8;nuclear magnetic resonance
8;ELISA
8;hybrid approach
8;super-resolution imaging
8;MS/MS
8;dynamic light scattering
8;quantitative method
8;open-source software
8;comparative analysis
8;Immunohistochemical analysis
8;live cell imaging
8;Microarray analysis
8;tandem mass spectrometry
8;Next-generation sequencing
8;cryoelectron microscopy
8;silico modeling
8;Exome sequencing
6;immunohistochemical analyses
6;enzyme-linked immunosorbent assay (ELISA)
6;orbital shaking method
6;Quo-Test
6;National Institute
6;model-predictive control algorithm
6;PRO-seq
6;bioinformatics pipeline
6;in vivo function
6;RNA-seq analysis
6;genetic approach
6;bioinformatics analysis
6;two-dimensional electrophoresis
6;machine learning techniques
6;IG-SVM
6;systematic review and meta-analysis
6;Transcriptomic analysis
6;magnetic resonance imaging (MRI)
6;retrospective analysis
6;TB-LAMP
6;systematic review
6;screen
6;machine-learning approach
6;RNAi screen
6;quantitative analysis
6;tilt-scheme
6;machine learning algorithms
6;label-free LC–MS/MS
6;optimized protocol
6;enzyme-linked immunosorbent assay
6;electron cryo-microscopy
6;Small-angle X-ray scattering
6;Genetic analysis
6;proposed method
6;optimal strategy
6;Southern blotting
6;multiple regression analysis
6;questionnaire
6;cross-sectional analysis
6;whole genome sequencing
6;genome-wide analysis
6;linear regression
6;molecular dynamics simulations
6;RT-qPCR
6;rapid method
6;1H NMR spectroscopy
6;case–control study
6;high-throughput techniques
6;proposed strategy
6;vitro selection
6;cDNA display
6;Regression analysis
6;16S rRNA gene sequencing
6;two methods
6;control strategy
6;prospective observational study
6;Histological analysis
6;techniques
6;elemental analysis
6;Bioinformatics analysis
6;electron microscopy (EM)
6;post-mortem
6;Crystallographic analysis
6;intravital imaging
6;gene expression profiling
6;intention to treat
6;gene expression analysis
6;Nuclear magnetic resonance (NMR) spectroscopy
6;vivo imaging
6;gas chromatography
6;laser Doppler imaging
6;fluorescence spectroscopy
6;systematic approach
6;atomic force microscopy
6;biochemical analysis
6;Fourier transform infrared spectroscopy
6;magnetic resonance imaging
6;mass spectroscopy
6;in-vivo
6;affinity chromatography
6;Bioinformatics analyses
6;Immunofluorescence microscopy
6;mass spectrometry analyses
6;Live imaging
6;homogeneous assay
6;LC–
6;LC–MS/MS
6;MALDI-TOF mass spectrometry
6;molecular dynamics
6;single-molecule imaging
6;Monte Carlo simulations
6;Computational modeling
6;Ingenuity Pathway Analysis
6;qPCR analysis
6;chromatin immunoprecipitation
6;gel electrophoresis
6;approaches
6;force spectroscopy
6;comprehensive analysis
6;whole-genome sequencing
6;RNA sequencing analysis
6;whole-exome sequencing (WES)
6;Immunoblot analysis
6;linkage analysis
6;Avon Longitudinal Study
6;semi-structured interviews
4;ERIC-PCR
4;structure-based model
4;key informant interviews
4;in-house MAT
4;flow cytometry, and immunohistochemical analysis
4;parallel plate method
4;One Health approach
4;new framework
4;new guidelines
4;LC-MS method
4;laboratory standard method
4;mediation analysis
4;Linear regression
4;structural Magnetic Resonance Imaging (sMRI) scan
4;Cox proportional hazards regression analysis
4;pre-test
4;cohort study
4;comprehensive metabolomics analysis
4;diagnostic algorithm
4;univariate analysis
4;HEPES method
4;first-in-human trial
4;lanthanum-based flocculation method
4;SC qPCR
4;LRE qPCR method
4;subgroup analysis
4;Sensitivity analysis
4;liquid chromatography with tandem mass spectrometry (LC-MS/MS)
4;LC-MS/MS-based technique
4;X-ray analysis
4;optical coherence tomography (OCT)
4;intervention
4;statin-based therapy
4;fixed-effects meta-analysis
4;random-effects meta-analysis
4;genetic analysis
4;Genetics of Diabetes Audit
4;Axon-seq
4;combinatorial therapy
4;Single-cell RNA sequencing
4;Bi-DOCS
4;bioinformatic approach
4;vivo experiments
4;PET-CT
4;HNE-immunohistochemistry
4;PET-CT analysis
4;immuno-spin trapping technique
4;computational approach
4;dual-energy X-ray absorptiometry (DXA)
4;Cancer Genome Atlas (TCGA)
4;two-photon imaging
4;Quantitative analysis
4;two-photon calcium imaging
4;clinical trial
4;negative-stain electron microscopy
4;genome editing technology
4;Super-resolution microscopy
4;computational modeling
4;proof-of-principle experiments
4;RNA sequencing (RNA-seq)
4;chromatin immunoprecipitation sequencing
4;Single-cell analysis
4;high-fat diet (HFD)
4;genome-wide RNAi screen
4;comprehensive genome-wide analysis
4;in situ hybridization
4;Intramural Research Program
4;Enrichment analysis
4;TGS technology
4;fluorescence in situ hybridization
4;supported vector machines
4;1D 1H NMR
4;theory
4;comparative approach
4;homology-independent metrics
4;SQM-DH methods
4;local structure-based methods
4;bioinformatic analysis
4;silico approaches
4;metabolic engineering approach
4;data mining
4;analytical method
4;guilt-by-association rule
4;alpha shape theory
4;ChIP-seq experiments
4;Systems biology
4;forward genetic approach
4;genome-wide
4;purification protocol
4;ultra-deep sequencing
4;complete-case specification
4;English Cancer Patient Experience Survey
4;SWATH MS
4;proof-of-principle study
4;theoretical fragment ion spectra mass spectrometry (SWATH MS)
4;sequential window acquisition
4;immunohistochemical staining
4;LC-MS/MS method
4;SILAC labelling
4;CDDO-me
4;MS/MS strategy
4;peptide MS/MS fingerprinting
4;trypsin digest
4;mass spectrometric analysis
4;1-step method
4;Whole genome sequencing
4;random-effects model
4;teaching exercise
4;Tajima's D statistic
4;Spearman's correlation
4;equalising strategy
4;multivariable linear regression
4;in vitro studies
4;non-linear filtering techniques
4;first stage
4;software
4;penalized methods
4;EDISON-WMW
4;WMW test
4;breath-holding test
4;meta-analyzed
4;cross-sectional studies
4;ultra-deep next generation sequencing
4;social network analysis
4;Genome-wide analyses
4;genome-wide screen
4;optogenetic approach
4;general method
4;Kato-Katz technique
4;lipidomic approach
4;next generation sequencing (NGS)
4;Sanger sequencing
4;modelling framework
4;dynamical systems theory
4;ambient mass spectrometry
4;label-free
4;ChIP-SICAP
4;targeted screen
4;RNA-seq analyses
4;Structural analysis
4;single-molecule FRET
4;systems-level understanding
4;integrated analysis
4;Metabolomics analysis
4;Mol. Genet.
4;fate-mapping experiments
4;Transcriptional analysis
4;sub-volume averaging
4;Pull-down assays
4;Sub-volume averaging
4;solid-state NMR
4;statistical framework
4;Image analysis
4;3D reconstruction
4;web-based tools
4;single particle cryoEM approach
4;automated method
4;one-step purification
4;traditional protocol
4;stable isotope labelling
4;detailed protocol
4;solution NMR spectroscopy
4;intravital two-photon microscopy
4;ribosome profiling method
4;Cryo-electron microscopy (cryo-EM)
4;single-cell RNA-sequencing
4;reliable method
4;FPOP–MS
4;DNA methylation analysis
4;AutoMeDIP-seq
4;XL-MS
4;cryo-fluorescence microscopy
4;single-particle cryo-EM
4;surface plasmon resonance experiments
4;double electron-electron resonance (DEER) spectroscopy
4;point mutagenesis
4;mass spectrometry (MS)-based proteomics
4;Proteomic studies
4;quantitative RT-PCR
4;LC/MS/MS
4;Genome-wide association studies
4;state-of-the-art methods
4;Genomic studies
4;single method
4;statistical methods
4;conventional method
4;RNA-sequencing
4;in-situ
4;improved methodology
4;Concatenated gene sequence analysis
4;fluorescence in situ hybridization
4;transmission electron microscopy (TEM)
4;X-ray diffraction (XRD)
4;Fourier transform infrared spectroscopy (FTIR)
4;AFLP analysis
4;Ni-NTA chromatography
4;polymerase chain reaction (PCR)
4;response surface methodology
4;Northern blot analysis
4;SDS-PAGE analysis
4;high-performance liquid chromatography
4;response surface methodology (RSM)
4;cross-sectional observational study
4;Medical Research Council National Survey
4;regression analyses
4;reverse genetics
4;ingenuity pathway analysis (IPA)
4;polymerase chain reaction
4;targeted next-generation sequencing
4;open ring trial
4;cryo-EM method
4;cryo-electron microscopy (cryo-EM)
4;synchrotron radiation circular dichroism spectroscopy
4;immunoassay
4;faecal egg count reduction test
4;reverse line blot assay
4;‘One Health’ concept
4;experimental technique
4;liquid chromatography – mass spectrometry
4;differential scanning fluorimetry
4;similar approach
4;Single-cell sequencing
4;data analysis
4;RNA Bioinformatics Center (RBC)
4;Bayesian approach
4;triangulation test
4;Phase 2 clinical study
4;International Standard Randomised Controlled Trial
4;DCE-MRI
4;SEMAC protocol
4;test
4;Intravital imaging
4;Neo-Rapid CARB test
4;reference method
4;three methods
4;Automated microscopy
4;PMMS-phage method
4;genomic analysis
4;Quantitative PCR
4;Michaelis–Menten equation
4;Logistic regression analysis
4;proof-of-concept study
4;flow cytometry and immunohistochemistry
4;ICP-MS analysis
4;new strategy
4;scanning electron microscopy (SEM)
4;quantitative fluorescence microscopy
4;mouse model
4;CT imaging
4;Time-lapse microscopy
4;quantitative real-time PCR
4;new protocol
4;Structural modeling
4;structure-based mutagenesis
4;cryo electron microscopy
4;in vivo calcium imaging
4;integrative modeling
4;single-particle electron cryomicroscopy
4;structure-function analysis
4;Biochemical analysis
4;high-throughput screen
4;flow cytometric analysis
4;case-control study
4;per-protocol analysis
4;fluorescence-activated cell sorting
4;Confocal microscopy
4;Topological data analysis
4;Bayesian network analysis
4;proof-of-concept studies
4;factor and cluster analyses
4;basophil activation test (BAT)
4;murine model
4;-control study
4;RT-PCR analysis
4;Homology modelling
4;two-electrode voltage-clamp electrophysiology
4;al.
4;multiple linear regression
4;LC–MS
4;mass spectrometry-based assays
4;mass spectrometry analysis
4;High-throughput sequencing
4;DNA-SIP
4;thermal imaging
4;FT-IR
4;Electron tomography
4;protein crystallography
4;Database analyses
4;cross-linking
4;electrophoretic mobility shift assays
4;X-ray scattering
4;tryptophan fluorescence spectroscopy
4;small-angle neutron scattering
4;model
4;homology modelling
4;computer modelling
4;whole-cell patch clamp
4;HPLC analysis
4;quantitative Taqman PCR
4;logistic regression analysis
4;kit approach
4;proof-of-principle
4;real time RT-PCR
4;immunofluorescence microscopy
4;multiplex PCR
4;co-immunoprecipitation
4;oocyte host-transfer method
4;computational strategy
4;ex-vivo
4;loss-of-function experiments
4;ultracentrifugation method
4;World Health Organization (WHO)
4;mass-spectrometry
4;method comparison
4;quantitative PCR
4;hydrophilic interaction liquid chromatography
4;Nuclear magnetic resonance (NMR)
4;synthetic biology approach
4;stimulated emission depletion microscopy
4;Cryo-electron microscopy
4;single-molecule fluorescence techniques
4;site-directed spin labeling
